Glidiab
Glidiab is a medication designed to manage blood sugar levels in individuals with type 2 diabetes. It contains Gliclazide, which belongs to the class of drugs known as sulfonylureas. Gliclazide works by stimulating the pancreas to release insulin, thereby helping to lower blood glucose levels. This medication is typically taken orally in tablet form and is most effective when combined with a proper diet and exercise regimen. Glidiab is intended for patients who do not achieve adequate control of their diabetes with diet and exercise alone. It is important to follow a healthcare provider's instructions to optimize the benefits of this treatment.Active substance:
GliclazidePharmachologic effect:
Gliclazide is a sulfonylurea antidiabetic medication that stimulates insulin secretion from the beta cells of the pancreas, thereby reducing blood glucose levels. It also improves peripheral insulin sensitivity and has beneficial effects on microcirculation.Indications:
- Type 2 diabetes mellitus when diet, exercise, and weight loss alone do not result in adequate glycemic control.
Contraindications:
- Hypersensitivity to gliclazide or any of the excipients
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
- Diabetic pre-coma and coma
- Severe renal or hepatic insufficiency
- Concomitant use with miconazole
- Pregnancy and lactation
Side effects:
In order of decreasing probability: Hypoglycemia, Nausea, Vomiting, Diarrhea, Constipation, Abdominal pain, Rash, Pruritus, Erythema, Dizziness, Headache
Dosing and Administration:
The usual starting dose is 30 mg once daily, taken with breakfast. The dose may be adjusted based on the patient's response, with a maximum recommended dose of 120 mg per day. Tablets should be swallowed whole with a glass of water.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Glidiab
in Cyrillic : Глидиаб
SUBSTANCE
Gliclazide
DOSAGE FORM
tablets
